{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:27:00Z","timestamp":1790148420363,"version":"4.0.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","award":["RO1-AI 42053"],"award-info":[{"award-number":["RO1-AI 42053"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","award":["U19 AI31496"],"award-info":[{"award-number":["U19 AI31496"]}]},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health","award":["R21 AI074791"],"award-info":[{"award-number":["R21 AI074791"]}]},{"name":"John R. Oishei Foundation, Buffalo, New York"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.08.067","type":"journal-article","created":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T15:27:02Z","timestamp":1378481222000},"page":"1579-1587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Vaccines against gonorrhea: Current status and future challenges"],"prefix":"10.1016","volume":"32","author":[{"given":"Ann E.","family":"Jerse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Bash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.067_bib0005","first-page":"S32","article-title":"Sexually transmitted diseases and infertility","volume":"21","author":"Westrom","year":"1994","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00000658-192807000-00012","article-title":"The surgical pathology of epididymitis","volume":"88","author":"Campbell","year":"1928","journal-title":"Ann Surg"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.spid.2005.06.006","article-title":"Gonococcal infections in neonates and young children","volume":"16","author":"Woods","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/157016212800618138","article-title":"Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects","volume":"10","author":"Jarvis GA","year":"2012","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0025","series-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0030","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0035","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0140-6736(97)02190-9","article-title":"Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/sti.2003.008300","article-title":"Sexual behaviour: related adverse health burden in the United States","volume":"81","author":"Ebrahim","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0968-8080(12)40653-X","article-title":"The threat of untreatable gonorrhoea: implications and consequences for reproductive and sexual morbidity","volume":"20","author":"Ndowa","year":"2012","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0050","series-title":"Antimicrobial resistance in Neisseria gonorrhoeae","author":"Tapsall","year":"2001"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(95)91380-7","article-title":"Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial","volume":"346","author":"Grosskurth","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0060","first-page":"8","article-title":"Impact of immunization on Haemophilus influenzae type b disease","volume":"5","author":"Madore","year":"1996","journal-title":"Infect Agents Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/sextrans-2011-050049","article-title":"Core groups, antimicrobial resistance and rebound in gonorrhoea in North America","volume":"88","author":"Chan","year":"2012","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0070","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2958.2011.07773.x","article-title":"Focusing homologous recombination: pilin antigenic variation in the pathogenic Neisseria","volume":"81","author":"Cahoon","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/CMR.17.4.965-981.2004","article-title":"The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women","volume":"17","author":"Edwards","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0080","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1574-6976.2010.00260.x","article-title":"Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria","volume":"35","author":"Sadarangani","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.chom.2007.11.002","article-title":"Host glycoprotein Gp96 and scavenger receptor SREC interact with PorB of disseminating Neisseria gonorrhoeae in an epithelial invasion pathway","volume":"2","author":"Rechner","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1365-2958.1999.01411.x","article-title":"Iron acquisition systems in the pathogenic Neisseria","volume":"32","author":"Schryvers","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0095","first-page":"219","article-title":"Genetic organization and regulation of antimicrobial efflux systems possessed by Neisseria gonorrhoeae and Neisseria meningitidis","volume":"3","author":"Shafer","year":"2001","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0100","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/IAI.64.8.3374-3378.1996","article-title":"Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae","volume":"64","author":"Gill","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0966-842X(02)00037-9","article-title":"The role of porins in neisserial pathogenesis and immunity","volume":"11","author":"Massari","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/09680519020080010501","article-title":"Phase variable changes in genes lgtA and lgtC within the lgtABCDE operon of Neisseria gonorrhoeae can modulate gonococcal susceptibility to normal human serum","volume":"8","author":"Shafer","year":"2002","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrmicro2713","article-title":"A bacterial siren song: intimate interactions between Neisseria and neutrophils","volume":"10","author":"Criss","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/IAI.00711-09","article-title":"Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses","volume":"78","author":"Packiam","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1749-6632.1994.tb44280.x","article-title":"Inflammatory cytokine response to experimental human infection with Neisseria gonorrhoeae","volume":"730","author":"Ramsey","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0130","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1086\/515372","article-title":"Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections","volume":"178","author":"Hedges","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/mi.2009.139","article-title":"Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection","volume":"3","author":"Feinen","year":"2010","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/mi.2011.38","article-title":"Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice","volume":"5","author":"Packiam","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/icb.2008.55","article-title":"Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses","volume":"86","author":"van Vliet","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0150","doi-asserted-by":"crossref","first-page":"46252","DOI":"10.1074\/jbc.M306587200","article-title":"The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner","volume":"278","author":"Fisette","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0155","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.174.6.3545","article-title":"Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent","volume":"174","author":"Singleton","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0160","doi-asserted-by":"crossref","first-page":"e41260","DOI":"10.1371\/journal.pone.0041260","article-title":"Neisseria gonorrhoeae suppresses dendritic cell-induced, antigen-dependent CD4 T cell proliferation","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0165","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.4049\/jimmunol.0802696","article-title":"Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome","volume":"182","author":"Duncan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0170","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1128\/IAI.67.8.3937-3946.1999","article-title":"Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections","volume":"67","author":"Hedges","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmicb.2011.00124","article-title":"Vaccines for gonorrhea: can we rise to the challenge?","volume":"2","author":"Zhu","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0180","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1128\/IAI.00552-08","article-title":"Regulatory T cells are locally induced during intravaginal infection of mice with Neisseria gonorrhoeae","volume":"76","author":"Imarai","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mi.2012.12","article-title":"Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-beta-dependent mechanisms","volume":"5","author":"Liu","year":"2012","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1574-695X.2010.00759.x","article-title":"Circulating levels of interleukin-17A and interleukin-23 are increased in patients with gonococcal infection","volume":"61","author":"Gagliardi","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni769","article-title":"Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes","volume":"3","author":"Boulton","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0200","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1128\/IAI.73.7.4171-4179.2005","article-title":"Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production","volume":"73","author":"Pantelic","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0205","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1128\/IAI.00355-09","article-title":"Opa+ and Opa\u2212 isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells","volume":"77","author":"Youssef","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0210","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.4049\/jimmunol.1100718","article-title":"Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae","volume":"188","author":"So","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0215","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI115770","article-title":"Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defenses","volume":"89","author":"Cohen","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0220","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJM198506273122606","article-title":"Gonococcal infection: a model of molecular pathogenesis","volume":"312","author":"Britigan","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0225","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1172\/JCI114040","article-title":"Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection","volume":"83","author":"Plummer","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a009820","article-title":"Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae","volume":"149","author":"Fox","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0235","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.164.5.1735","article-title":"Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum","volume":"164","author":"Rice","year":"1986","journal-title":"J Exp Med"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2013.08.067_bib0240","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1128\/CMR.2.Suppl.S56","article-title":"Animal models for pathogenic Neisseria species","volume":"2","author":"Arko","year":"1989","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2013.08.067_bib0245","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1086\/513847","article-title":"Human experimentation with Neisseria gonorrhoeae: progress and goals","volume":"179","author":"Cohen","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fmicb.2011.00123","article-title":"Experimental gonococcal infection in male volunteers: cumulative experience with Neisseria gonorrhoeae strains FA1090 and MS11mkC","volume":"2","author":"Hobbs","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0255","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00007435-200110000-00001","article-title":"Experimental gonococcal urethritis and reinfection with homologous gonococci in male volunteers","volume":"28","author":"Schmidt","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1099\/00222615-30-1-33","article-title":"Resistance of mice to genital infection with Neisseria gonorrhoeae","volume":"30","author":"Johnson","year":"1989","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0265","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmicb.2011.00107","article-title":"Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections","volume":"2","author":"Jerse","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0270","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/315801","article-title":"Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae","volume":"182","author":"Plante","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0275","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/infdis\/139.1.89","article-title":"Studies on gonococcus infection. XVII. IgA1-cleaving protease in vaginal washings from women with gonorrhea","volume":"139","author":"Blake","year":"1979","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0280","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1128\/IAI.66.12.5826-5832.1998","article-title":"Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae","volume":"66","author":"Hedges","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0285","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1286-4579(02)01585-X","article-title":"Humoral immune responses to microbial infections in the genital tract","volume":"4","author":"Russell","year":"2002","journal-title":"Microbes Infect"},{"issue":"Suppl 8","key":"10.1016\/j.vaccine.2013.08.067_bib0290","doi-asserted-by":"crossref","first-page":"I62","DOI":"10.1016\/j.vaccine.2008.11.051","article-title":"Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?","volume":"26","author":"Ngampasutadol","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0295","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0300","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1016\/j.vaccine.2007.07.038","article-title":"Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice","volume":"25","author":"Price","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0305","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1128\/IAI.73.7.3945-3953.2005","article-title":"Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice","volume":"73","author":"Price","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0310","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","article-title":"Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor \u03b3 chain(null) mice","volume":"106","author":"Ishikawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0315","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0264-410X(91)90147-X","article-title":"Efficacy trial of a parenteral gonococcal pilus vaccine in men","volume":"9","author":"Boslego","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0320","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2958.1998.00710.x","article-title":"The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers","volume":"27","author":"Cornelissen","year":"1998","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0325","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/174.6.1223","article-title":"Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids","volume":"174","author":"Gulati","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.vaccine.2005.07.065","article-title":"Characterization of a peptide vaccine candidate mimicking an oligosaccharide epitope of Neisseria gonorrhoeae and resultant immune responses and function","volume":"24","author":"Ngampasutadol","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0335","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1073\/pnas.95.18.10872","article-title":"Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae","volume":"95","author":"Banerjee","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0340","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1006\/jmbi.2001.5251","article-title":"Crystal structure of the soluble domain of the major anaerobically induced outer membrane protein (AniA) from pathogenic Neisseria: a new class of copper-containing nitrite reductases","volume":"315","author":"Boulanger","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2012.12.132","article-title":"Recombinant truncated AniA of pathogenic Neisseria elicits a non-native immune response and functional blocking antibodies","author":"Shewell","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0882-4010(88)90038-1","article-title":"Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections","volume":"5","author":"Clark","year":"1988","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0355","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fmicb.2011.00075","article-title":"The composition and metabolic phenotype of Neisseria gonorrhoeae biofilms","volume":"2","author":"Falsetta","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0360","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0365","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2013.08.067_bib0370","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0375","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1600-0463.2012.02903.x","article-title":"Novel meningococcal 4CMenB vaccine antigens \u2013 prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae","volume":"120","author":"Hadad","year":"2012","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0380","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/0264-410X(95)00100-F","article-title":"Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus","volume":"13","author":"Gallichan","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0385","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/IAI.64.4.1272-1283.1996","article-title":"Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit","volume":"64","author":"Russell","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0390","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1128\/IAI.68.10.5539-5545.2000","article-title":"Generation of female genital tract antibody responses by local or central (common) mucosal immunization","volume":"68","author":"Wu","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0395","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/IAI.69.12.7481-7486.2001","article-title":"Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans","volume":"69","author":"Johansson","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0400","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1188454","article-title":"Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses","volume":"328","author":"Hapfelmeier","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0405","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0410","article-title":"Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties","author":"Hajishengallis","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vetimm.2012.09.034","article-title":"Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties","volume":"152","author":"Hajishengallis","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0420","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/IAI.61.1.314-322.1993","article-title":"Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit","volume":"61","author":"Wu","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0425","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0430","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/erv.09.13","article-title":"IL-12 as an adjuvant for the enhancement of protective humoral immunity","volume":"8","author":"Metzger","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0435","doi-asserted-by":"crossref","first-page":"289597","DOI":"10.1155\/2011\/289597","article-title":"Cytokines: the future of intranasal vaccine adjuvants","volume":"2011","author":"Thompson","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0440","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0445","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2958.1997.4601823.x","article-title":"PilC of pathogenic Neisseria is associated with the bacterial cell surface","volume":"25","author":"Rahman","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0450","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/373357a0","article-title":"Neisseria PilC protein identified as type-4 pilus tip-located adhesin","volume":"373","author":"Rudel","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0455","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.vaccine.2011.12.076","article-title":"Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis","volume":"30","author":"Haghi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0460","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.01338-10","article-title":"Potential of recombinant Opa proteins as vaccine candidates against hyperinvasive meningococci","volume":"79","author":"Callaghan","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0465","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.vaccine.2004.03.047","article-title":"Intranasal immunisation of mice with liposomes containing recombinant meningococcal OpaB and OpaJ proteins","volume":"22","author":"de Jonge","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0470","doi-asserted-by":"crossref","first-page":"e8108","DOI":"10.1371\/journal.pone.0008108","article-title":"Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops","volume":"4","author":"Cole","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0475","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fmicb.2011.00117","article-title":"TonB-dependent transporters expressed by Neisseria gonorrhoeae","volume":"2","author":"Cornelissen","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0480","doi-asserted-by":"crossref","first-page":"e1000969","DOI":"10.1371\/journal.ppat.1000969","article-title":"An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential","volume":"6","author":"Stork","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0485","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/IAI.70.7.3744-3751.2002","article-title":"The Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is a surface-exposed outer membrane protein","volume":"70","author":"Shell","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0490","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1365-2958.2007.05745.x","article-title":"Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization","volume":"64","author":"Serino","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0495","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-1119(02)01208-8","article-title":"Identification of opcA gene in Neisseria polysaccharea: interspecies diversity of Opc protein family","volume":"307","author":"Zhu","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0500","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00095-11","article-title":"Diversion of the immune response to Neisseria gonorrhoeae from Th17 to Th1\/Th2 by treatment with anti-transforming growth factor beta antibody generates immunological memory and protective immunity","volume":"2","author":"Liu","year":"2011","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0505","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fmicb.2011.00052","article-title":"New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host","volume":"2","author":"Liu","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0510","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0002-9378(16)39663-6","article-title":"A study of cervical cultures taken in cases of acute gonorrhea with special reference to the phases of the menstrual cycle","volume":"54","author":"Koch","year":"1947","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0515","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.1982.03320340046033","article-title":"Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae","volume":"247","author":"McCormack","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0540","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/IAI.00996-09","article-title":"Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control","volume":"78","author":"Cole","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0525","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/IAI.01085-09","article-title":"Neisseria gonorrhoeae survival during primary human cervical epithelial cell infection requires nitric oxide and is augmented by progesterone","volume":"78","author":"Edwards","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0530","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/367658","article-title":"Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection","volume":"36","author":"Wiesenfeld","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.067_bib0535","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/597390","article-title":"Hydrogen peroxide-producing lactobacilli inhibit gonococci in vitro but not during experimental genital tract infection","volume":"199","author":"Muench","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T09:27:31Z","timestamp":1596446851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":107,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X13011791"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines against gonorrhea: Current status and future challenges","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}